TH180316A - The regulator modifies the transport through the nucleus and its use. - Google Patents
The regulator modifies the transport through the nucleus and its use.Info
- Publication number
- TH180316A TH180316A TH1501007614A TH1501007614A TH180316A TH 180316 A TH180316 A TH 180316A TH 1501007614 A TH1501007614 A TH 1501007614A TH 1501007614 A TH1501007614 A TH 1501007614A TH 180316 A TH180316 A TH 180316A
- Authority
- TH
- Thailand
- Prior art keywords
- page
- formula
- pharmacologically acceptable
- ocr
- salts
- Prior art date
Links
- 210000004940 Nucleus Anatomy 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract 7
- 239000011780 sodium chloride Substances 0.000 claims abstract 7
- 150000001875 compounds Chemical class 0.000 claims abstract 6
- 239000000126 substance Substances 0.000 claims abstract 5
- 239000000470 constituent Substances 0.000 claims abstract 3
- 102100014004 XPO1 Human genes 0.000 claims abstract 2
- 201000010099 disease Diseases 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims abstract 2
- 108091004173 exportin 1 protein Proteins 0.000 claims abstract 2
- 125000004429 atoms Chemical group 0.000 claims 2
- 239000005426 pharmaceutical component Substances 0.000 claims 1
Abstract
------15/12/2560------(OCR) หน้า 1 ของจำนวน 1 หน้า บทสรุปการประดิษฐ์ การประดิษฐ์นี้เกี่ยวข้องกับสารประกอบที่มีสูตร I (สูตรเคมี) และเกลือที่ยอมรับได้ทางเภสัชกรรมของสิ่งนั้น, องค์ประกอบทางเภสัชกรรมซึ่งประกอบ รวมด้วยสารประกอบที่มีสูตร I หรือเกลือที่ยอมรับได้ทางเภสัชกรรมของสารเหล่านั้น และวิธีการใน การใช้สารประกอบดังกล่าว, เกลือและองค์ประกอบดังกล่าวในการบำบัดความผิดปกติหลายชนิดที่ เกี่ยวข้องกับกัมมันตภาพของ CRM1 ------------ : สิทธิบัตรยา ------ 15/12/2017 ------ (OCR) page 1 of number 1 page invention summary. This invention involves a compound with formula I (chemical formula) and a pharmaceutical acceptable salt of that, the pharmaceutical constituents that make up the Combined with compounds with formula I or pharmacologically acceptable salts of those substances and the methods for their use, the salts and their constituents in the treatment of many disorders where Related to the activity of CRM1 ------------: Drug patent.
Claims (2)
Publications (2)
Publication Number | Publication Date |
---|---|
TH1501007614A TH1501007614A (en) | 2018-10-04 |
TH180316A true TH180316A (en) | 2018-10-04 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017000541A1 (en) | Compounds and compositions as raf kinase inhibitors | |
CL2017000117A1 (en) | Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity. | |
TH180316A (en) | The regulator modifies the transport through the nucleus and its use. | |
CL2016003230A1 (en) | Compounds, pharmaceutical composition and its use in the treatment of neurodegenerative diseases | |
TH177040A (en) | Fumagillol derivatives | |
TH168042A (en) | Indolon derivatives replaced with - pirroll, methods of preparation therefore, constituent elements and their use. | |
TH1701001398A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-il compounds And using it as a SGRM controller | |
TH1601003309A (en) | ||
TH1601003714A (en) | SYK inhibitors | |
TH169613A (en) | NR2B selective Antagonist type | |
TH1701002063A (en) | Aldosteron Synthes inhibitors | |
TH177040B (en) | Fumagillol derivatives | |
TH167559A (en) | 2-aminopyrimidine derivatives for the treatment of viral infections. | |
TH168637B (en) | New heterocyclic compounds | |
TH180875A (en) | Chemical compound | |
Otto | Ocular Health Study Interim Data Analysis | |
TH1801004478A (en) | Steroid Derivative FXR Agent | |
TH1701006461A (en) | An amino-hydrothiazine derivative fused by tetrahydrofurane, useful in the treatment of Alzheimer's disease. | |
TH174458A (en) | Pharmaceutical solids containing biotherin derivatives And the use of such elements | |
TH146336A (en) | Pyridazinone compounds and their use as DAAO inhibitors | |
TH1501002091A (en) | Benzene displaced compounds | |
TH168637A (en) | New heterocyclic compounds | |
TH182678A (en) | Tetrahydroquinoline derivatives, bromodomain inhibitors | |
TH182729A (en) | Phenoxymethyl derivatives | |
TH168988A (en) | Fibroblast growth factor receptor inhibitor |